{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:35:05Z","timestamp":1787740505829,"version":"build-2784847793"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a multifactorial neurodegenerative condition with symptoms such as resting tremor, rigidity, bradykinesia (slowness of moment), and postural instability. Neuroinflammation plays a significant part in the onset and progression of neurodegeneration in a wide range of disorders, including PD. The loss of dopaminergic neurons in the substantia nigra (SN) is thought to be the primary cause of PD disease progression. However, other neurotransmitter systems like serotoninergic, glutamatergic, noradrenergic, adrenergic, cholinergic, tryptaminergic, and peptidergic appear to be affected as well. Epigenetic regulation of gene expression is emerging as an influencing factor in the pathophysiology of PD. In recent years, epigenetic regulation by microRNAs (miRNAs) has been discovered to play an important function in the disease progression of PD. This review explores the role of miRNAs and their signaling pathways in regulating gene expression from development through neurodegeneration and how these mechanisms are linked to the pathophysiology of PD, emphasizing potential therapeutic interventions.<\/jats:p>","DOI":"10.3389\/fncel.2022.995997","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:58:35Z","timestamp":1663333115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNAs in the epigenetic regulation of disease progression in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Sushmaa Chandralekha","family":"Selvakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Auxzilia","family":"Preethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deusdedit","family":"Tusubira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durairaj","family":"Sekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1515\/bmc-2014-0012","article-title":"Update on non-canonical microRNAs.","volume":"5","author":"Abdelfattah","year":"2014","journal-title":"Biomol. Concepts"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104515","article-title":"miR-124 and Parkinson\u2019s disease: A biomarker with therapeutic potential.","volume":"150","author":"Angelopoulou","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson Disease: A review.","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biopha.2015.07.034","article-title":"Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson\u2019s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway.","volume":"75","author":"Ba","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"22390","DOI":"10.18632\/aging.203545","article-title":"Deficiency of miR-29b2\/c leads to accelerated aging and neuroprotection in MPTP-induced Parkinson\u2019s disease mice.","volume":"13","author":"Bai","year":"2021","journal-title":"Aging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function.","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2741\/s415","article-title":"Parkinson\u2019s disease: A review.","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11481-017-9732-y","article-title":"TGF-\u03b21 neuroprotection via inhibition of microglial activation in a rat model of Parkinson\u2019s disease.","volume":"12","author":"Chen","year":"2017","journal-title":"J. Neuroimmun. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/hmg\/dds470","article-title":"MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein.","volume":"22","author":"Cho","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1101\/gad.1953310","article-title":"Canonical and alternate functions of the microRNA biogenesis machinery.","volume":"24","author":"Chong","year":"2010","journal-title":"Genes Develop."},{"key":"B11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12031-018-1231-y","article-title":"miR-34a in neurophysiology and neuropathology.","volume":"67","author":"Chua","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11064-019-02910-5","article-title":"Pramipexole inhibits MPP+-induced neurotoxicity by miR-494-3p\/BDNF.","volume":"45","author":"Deng","year":"2020","journal-title":"Neurochem. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex.","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11192","DOI":"10.26355\/eurrev_202011_23607","article-title":"MiR-133b inhibits MPP+-induced apoptosis in Parkinson\u2019s disease model by inhibiting the ERK1\/2 signaling pathway.","volume":"24","author":"Dong","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11064-020-03166-0","article-title":"MiR-421 aggravates neurotoxicity and promotes cell death in Parkinson\u2019s disease models by directly targeting MEF2D.","volume":"46","author":"Dong","year":"2021","journal-title":"Neurochem. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12035-020-02101-2","article-title":"The relation of the brain-derived neurotrophic factor with micrornas in neurodegenerative diseases and ischemic stroke.","volume":"58","author":"Eyileten","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104587","article-title":"Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against \u03b2-amyloid by targeting DAPK-1 and TP53.","volume":"118","author":"Guo","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis.","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13518","DOI":"10.18632\/aging.103458","article-title":"Association of the serum microRNA-29 family with cognitive impairment in Parkinson\u2019s disease.","volume":"12","author":"Han","year":"2020","journal-title":"Aging"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1093\/nar\/gks026","article-title":"Biogenesis of mammalian microRNAs by a non-canonical processing pathway.","volume":"40","author":"Havens","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1809-5","article-title":"miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease.","volume":"10","author":"Hu","year":"2019","journal-title":"Cell Death Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/jnen\/nlac049","article-title":"Bone marrow stem cell-exo-derived TSG-6 attenuates 1-methyl-4-phenylpyridinium+-induced neurotoxicity via the STAT3\/miR-7\/NEDD4\/LRRK2 Axis.","volume":"81","author":"Huang","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12461","article-title":"Let-7b-5p promotes cell apoptosis in Parkinson\u2019s disease by targeting HMGA2.","volume":"24","author":"Huang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"74484","DOI":"10.18632\/oncotarget.12811","article-title":"Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1\/mTOR signal pathway.","volume":"7","author":"Kou","year":"2016","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/21655979.2021.2015527","article-title":"Long non-coding RNA myocardial infarction-associated transcript promotes 1-Methyl-4-phenylpyridinium ion-induced neuronal inflammation and oxidative stress in Parkinson\u2019s disease through regulating microRNA-221-3p\/transforming growth factor\/nuclear factor E2-related factor 2 axis.","volume":"13","author":"Lang","year":"2022","journal-title":"Bioengineered"},{"key":"B26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.chemosphere.2019.05.064","article-title":"Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor\/\u03b1-synuclein axis in atrazine-induced Parkinson\u2019s disease by peripheral blood and brain microRNA profiling.","volume":"233","author":"Li","year":"2019","journal-title":"Chemosphere"},{"key":"B27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s13577-017-0187-5","article-title":"MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson\u2019s disease by targeting Nlrp3.","volume":"31","author":"Li","year":"2018","journal-title":"Hum. Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1189","article-title":"MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson\u2019s disease.","volume":"8","author":"Li","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4149\/BLL_2018_005","article-title":"Protective role of microRNA-221 in Parkinson\u2019s disease.","volume":"119","author":"Li","year":"2018","journal-title":"Bratislavske Lekarske Listy"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4894","article-title":"miR-335 promotes ferroptosis by targeting ferritin heavy chain 1 in in vivo and in vitro models of Parkinson\u2019s disease.","volume":"47","author":"Li","year":"2021","journal-title":"Int. J. Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jnc.15299","article-title":"MicroRNA-3473b regulates the expression of TREM2\/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease.","volume":"157","author":"Lv","year":"2021","journal-title":"J. Neurochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.brainresbull.2020.10.019","article-title":"Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson\u2019s disease via suppression of LASP1.","volume":"166","author":"Ma","year":"2021","journal-title":"Brain Res. Bull."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1021\/acschemneuro.1c00076","article-title":"MiR-30a-5p regulates GLT-1 function via a PKC\u03b1-mediated ubiquitin degradation pathway in a mouse model of Parkinson\u2019s disease.","volume":"12","author":"Meng","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation.","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060945","article-title":"Circulating inflammatory miRNAs associated with Parkinson\u2019s disease pathophysiology.","volume":"10","author":"Oliveira","year":"2020","journal-title":"Biomolecules"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.661461","article-title":"miR-335 targets LRRK2 and mitigates inflammation in Parkinson\u2019s disease.","volume":"9","author":"Oliveira","year":"2021","journal-title":"Front. Cell Develop. Biol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 Countries\/Territories From 1990 to 2019.","volume":"9","author":"Ou","year":"2021","journal-title":"Front. Public Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/0028-3886.310102","article-title":"Preliminary study of hsa-mir-626 change in the cerebrospinal fluid in Parkinson\u2019s disease.","volume":"69","author":"Qin","year":"2021","journal-title":"Neurol. India"},{"key":"B39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/1061186X.2021.1886300","article-title":"MicroRNA-185 activates PI3K\/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson\u2019s disease.","volume":"29","author":"Qin","year":"2021","journal-title":"J. Drug Target."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010440","article-title":"The evolving landscape of exosomes in neurodegenerative diseases: Exosomes characteristics and a promising role in early diagnosis.","volume":"22","author":"Rastogi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1503\/cmaj.151179","article-title":"An update on the diagnosis and treatment of Parkinson disease.","volume":"188","author":"Rizek","year":"2016","journal-title":"CMAJ"},{"key":"B42","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods.","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.biopsych.2018.12.008","article-title":"MicroRNA-26a\/Death-associated protein kinase 1 signaling induces synucleinopathy and dopaminergic neuron degeneration in Parkinson\u2019s disease.","volume":"85","author":"Su","year":"2019","journal-title":"Biol. Psychiatr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2016.12.014","article-title":"MicroRNA-712 restrains macrophage pro-inflammatory responses by targeting LRRK2 leading to restoration of insulin stimulated glucose uptake by myoblasts.","volume":"82","author":"Talari","year":"2017","journal-title":"Mol. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3892\/ijmm.2019.4426","article-title":"miRNA-384-5p regulates the progression of Parkinson\u2019s disease by targeting SIRT1 in mice and SH-SY5Y cell.","volume":"45","author":"Tao","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Trans."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","article-title":"MiRNA biogenesis and regulation of diseases: An overview.","volume":"1509","author":"Vishnoi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.104972","article-title":"Pramipexole attenuates neuronal injury in Parkinson\u2019s disease by targeting miR-96 to activate BNIP3-mediated mitophagy.","volume":"146","author":"Wang","year":"2021","journal-title":"Neurochem. Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/gtc.12764","article-title":"miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson\u2019s disease.","volume":"25","author":"Wang","year":"2020","journal-title":"Genes Cells"},{"key":"B50","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/gtc.12877","article-title":"miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson\u2019s disease models.","volume":"26","author":"Wang","year":"2021","journal-title":"Genes Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"724","DOI":"10.26355\/eurrev_201901_16886","article-title":"MicroRNA-599 regulates the development of Parkinson\u2019s disease through mediating LRRK2 expression.","volume":"23","author":"Wu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1021\/acschemneuro.8b00683","article-title":"Regulatory mechanism of miR-543-3p on GLT-1 in a mouse model of Parkinson\u2019s disease.","volume":"10","author":"Wu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11011-020-00546-x","article-title":"MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson\u2019s disease model by targeting Bax.","volume":"35","author":"Yang","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1021\/acschemneuro.8b00460","article-title":"Altered expression levels of microRNA-132 and Nurr1 in peripheral blood of Parkinson\u2019s disease: Potential disease biomarkers.","volume":"10","author":"Yang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1096\/fj.201900363R","article-title":"MicroRNA-124 regulates the expression of p62\/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease.","volume":"33","author":"Yao","year":"2019","journal-title":"FASEB J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1089\/omi.2016.0040","article-title":"Hypothesis: Do mirnas targeting the leucine-rich repeat kinase 2 gene (LRRK2) influence Parkinson\u2019s disease susceptibility?","volume":"20","author":"Y\u0131lmaz","year":"2016","journal-title":"Omics"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-06539-3","article-title":"Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease.","volume":"12","author":"Yousefi","year":"2022","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1007\/s12035-021-02298-w","article-title":"DNA methyltransferase 1 is dysregulated in Parkinson\u2019s disease via mediation of miR-17.","volume":"58","author":"Zhang","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neulet.2017.10.014","article-title":"Inhibition of BDNF production by MPP+ through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model.","volume":"675","author":"Zhang","year":"2018","journal-title":"Neurosci. Lett."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: Biogenesis, biologic function and clinical potential.","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"14995","DOI":"10.1002\/jcb.28761","article-title":"MicroRNA-326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson\u2019s disease.","volume":"120","author":"Zhao","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105197","article-title":"miR-103a-3p regulates mitophagy in Parkinson\u2019s disease through Parkin\/Ambra1 signaling.","volume":"160","author":"Zhou","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.18632\/aging.202378","article-title":"LncRNA XIST sponges miR-199a-3p to modulate the Sp1\/LRRK2 signal pathway to accelerate Parkinson\u2019s disease progression.","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8814862","article-title":"Downregulation of microRNA-15b-5p targeting the Akt3-mediated GSK-3\u03b2\/\u03b2-catenin signaling pathway inhibits cell apoptosis in Parkinson\u2019s disease.","volume":"2021","author":"Zhu","year":"2021","journal-title":"BioMed. Res. Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/tox.23344","article-title":"Silencing of miR-497-5p inhibits cell apoptosis and promotes autophagy in Parkinson\u2019s disease by upregulation of FGF2.","volume":"36","author":"Zhu","year":"2021","journal-title":"Environ. Toxicol."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2022.995997\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T12:58:39Z","timestamp":1663333119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2022.995997\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":65,"alternative-id":["10.3389\/fncel.2022.995997"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2022.995997","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"article-number":"995997"}}